General - Pulmonary
Payments companies reported to CMS as associated with General - Pulmonary. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with General - Pulmonary, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with General - Pulmonary
These are the largest totals companies reported as associated with General - Pulmonary. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Mihir Parikh | Boston, MA | Internal Medicine | $107.26 |
| Kai Swenson | Boston, MA | Pulmonary Disease | $107.26 |
| Adnan Majid | Boston, MA | Pulmonary Disease | $107.26 |
| Jason Beattie | Boston, MA | Pulmonary Disease | $107.26 |
| Ayman Abdul Ghani | Honolulu, HI | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $84.90 |
| Eric Crawley | Honolulu, HI | Pulmonary Disease | $84.89 |
| Christian Castaneda | Honolulu, HI | Critical Care Medicine (Internal Medicine) | $84.89 |
| Katy Marino | Little Rock, AR | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $76.87 |
| Hashim Ahmed | Fort Worth, TX | $26.04 | |
| Neal Desai | Fort Worth, TX | Vascular & Interventional Radiology | $26.04 |
Prescribed General - Pulmonary?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.